{
  "paper_metadata": {
    "pmid": "36303204",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for the KCNH2 gene, including penetrance data for affected and unaffected carriers."
  },
  "variants": [
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": "c.G2075A",
      "protein_notation": "p.Arg692Gln",
      "genomic_position": "chr7:150644473",
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "1 patient, male, age 32",
        "phenotype": "Brugada syndrome, ICD therapy"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 18",
          "age_at_evaluation": 32,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "ICD therapy",
          "evidence_sentence": "KCNH2 (p.R692Q) may cause Brugada syndrome."
        }
      ],
      "functional_data": {
        "summary": "The variant is predicted to be damaging based on computational tools.",
        "assays": []
      },
      "segregation_data": "Not mentioned",
      "population_frequency": "Not available",
      "evidence_level": "Moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant is associated with Brugada syndrome.",
      "key_quotes": [
        "KCNH2 (p.R692Q) may cause Brugada syndrome."
      ]
    },
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": "c.G481A",
      "protein_notation": "p.Asp161Asn",
      "genomic_position": "chr7:150649569",
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "1 patient, female, age 16",
        "phenotype": "Long QT syndrome, ICD therapy"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 21",
          "age_at_evaluation": 16,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ICD therapy",
          "evidence_sentence": "KCNH2 (p.D161N) may lead to long QT syndrome."
        }
      ],
      "functional_data": {
        "summary": "The variant is predicted to be damaging based on computational tools.",
        "assays": []
      },
      "segregation_data": "Not mentioned",
      "population_frequency": "Not available",
      "evidence_level": "Moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant is associated with Long QT syndrome.",
      "key_quotes": [
        "KCNH2 (p.D161N) may lead to long QT syndrome."
      ]
    },
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": "c.563_564del",
      "protein_notation": "p.A188Gfs*143",
      "genomic_position": "chr7:150655499",
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "1 patient, age 16",
        "phenotype": "Long QT syndrome, ICD therapy"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 13",
          "age_at_evaluation": 16,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ICD therapy",
          "evidence_sentence": "A patient of LQTs carried a frameshift mutation of KCNH2 p.A188Gfs*143."
        }
      ],
      "functional_data": {
        "summary": "The variant is predicted to result in a truncated protein.",
        "assays": []
      },
      "segregation_data": "Not mentioned",
      "population_frequency": "Not available",
      "evidence_level": "Moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant is associated with Long QT syndrome.",
      "key_quotes": [
        "A patient of LQTs carried a frameshift mutation of KCNH2 p.A188Gfs*143."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 2",
      "table_caption": "The known and likely pathogenic mutations of Brugada syndrome and long QT syndrome",
      "variants_extracted": 3
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 3,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant KCNH2 variants were extracted successfully."
  }
}